raubasine has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C | 1 |
| Guez, D | 1 |
| Carbonin, PU; Cattelin, F; Gemma, A; Greco, A; Pisanti, P | 1 |
2 trial(s) available for raubasine and Cognition Disorders
| Article | Year |
|---|---|
Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
Topics: Aged; Aged, 80 and over; Almitrine; Anxiety; Cognition Disorders; Depression; Double-Blind Method; Drug Combinations; Female; Humans; Male; Memory; Psychological Tests; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
1 other study(ies) available for raubasine and Cognition Disorders
| Article | Year |
|---|---|
Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
Topics: Aged; Aging; Almitrine; Cognition Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1990 |